Latest Concord Biotech stock price

Concord Biotech P/E Ratio

CONCORDBIO • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
41.93
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 41.93
Current Price ₹1200.90
EPS (TTM) ₹35.52
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 50.69
Historical Range 32.39 - 72.25
Percentile 33.3%

Sector Context

Sector Average 48.13
Sector Median 27.3
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹29.74
Sept 2025 ₹6.03
Mar 2025 ₹13.42

Key P/E Ratio Insights for Concord Biotech

  • Stock appears overvalued with PE of 41.93, suggesting caution for new investments
  • Trading at discount to sector average PE of 48.13

View the CONCORDBIO equity price for detailed stock performance.

P/E Ratio Historical Trend for Concord Biotech

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 72.25 29.74 ₹2148.75 NSE High
2024 47.43 31.19 ₹1479.40 NSE High
2023 32.39 29.11 ₹942.80 NSE High

Sector P/E Ratio Comparison

Comparing Concord Biotech with other companies in Healthcare sector
Sector Average
48.13
Sector Median
27.3
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.1 ₹38 Low
Murae Organisor MURAE 3.14 ₹47 Low
Ind Swift Laboratories INDSWFTLAB 4.87 ₹1,186 Low
Amwill Health Care AMWILL 6.5 ₹67 Low
Medicamen Organics MEDIORG 6.94 ₹27 Low
JFL Life Sciences JFLLIFE 7.53 ₹36 Low
Galaxy Medicare GML 7.66 ₹26 Low
Unichem Laboratories UNICHEMLAB 8.42 ₹2,437 Low
Zenith Drugs ZENITHDRUG 9.03 ₹85 Low
Brooks Laboratories BROOKS 9.44 ₹198 Low